Curexo Inc. (KOSDAQ:060280)
11,000
+430 (4.07%)
Jun 12, 2026, 3:30 PM KST
Curexo Revenue
Curexo had revenue of 16.10B KRW in the quarter ending March 31, 2026, a decrease of -18.34%. This brings the company's revenue in the last twelve months to 70.92B, up 15.69% year-over-year. In the year 2025, Curexo had annual revenue of 74.53B with 34.22% growth.
Revenue (ttm)
70.92B
Revenue Growth
+15.69%
P/S Ratio
6.40
Revenue / Employee
675.41M
Employees
105
Market Cap
453.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.53B | 19.00B | 34.22% |
| Dec 31, 2024 | 55.53B | 28.00B | 101.72% |
| Dec 31, 2015 | 27.53B | 1.39B | 5.33% |
| Dec 31, 2014 | 26.14B | -4.95B | -15.93% |
| Dec 31, 2013 | 31.09B | 6.81B | 28.05% |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seegene | 487.37B |
| i-SENS | 314.31B |
| InBody Co.,Ltd | 246.81B |
| WON TECH | 159.67B |
| DRTECH | 122.78B |
| Osang Healthcare Co.,Ltd | 119.38B |
| L&C BIO Co.,LTD | 98.10B |
| Bio Plus | 94.42B |